Release of Moxifloxacin From Corneal Collagen Shields

Zhou, S. P.; Hunt, Kristin M.; Grewal, A. S.; Dhaliwal, Deepinder K.; Shanks, Robert M. Q.

doi:10.1097/icl.0000000000000421

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Release of Moxifloxacin From Corneal Collagen Shields

Abstract: Moxifloxacin diffuses through BCLs and CSs at similar rates; however, CSs have greater capacity to absorb and release moxifloxacin compared with BCLs. Vigamox-soaked CSs released 250 μg of moxifloxacin and may be a useful method to prevent endophthalmitis.

Cited by 4 publications

References 31 publications

First experience with Oasis Collagen SOFT SHIELD® for epithelial defect after corneal cross-linking

First experience with Oasis Collagen SOFT SHIELD® for epithelial defect after corneal cross-linking

Optimized molecular imprints in gamma-irradiated collagen shields of an antifungal drug: In vitro characterization, in-vivo bioavailability enhancement

Testing drug release from medicated contact lenses: The missing link to predict in vivo performance

Contact Info

Product

Resources

About